Terms: = Brain cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Treatment
157 results:
1. Inhibition of PRMT1 Suppresses the Growth of U87MG-Derived Glioblastoma Stem Cells by Blocking the STAT3 Signaling Pathway.
Yuk N; Jung HJ
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474197
[TBL] [Abstract] [Full Text] [Related]
2. RhoGDIβ inhibition via miR-200c/AUF1/sox2/miR-137 axis contributed to lncRNA MEG3 downregulation-mediated malignant transformation of human bronchial epithelial cells.
Yang Y; Tian Z; He L; Meng H; Xie X; Yang Z; Wang X; Zhao Y; Huang C
Mol Carcinog; 2024 May; 63(5):977-990. PubMed ID: 38376344
[TBL] [Abstract] [Full Text] [Related]
3. EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4/integrin β1 signalling axis.
Huang YH; Wang WL; Wang PH; Lee HT; Chang WW
Int J Biol Sci; 2024; 20(1):265-279. PubMed ID: 38164180
[TBL] [Abstract] [Full Text] [Related]
4. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer.
Zu L; He J; Zhou N; Tang Q; Liang M; Xu S
Cell Death Dis; 2023 Dec; 14(12):798. PubMed ID: 38057344
[TBL] [Abstract] [Full Text] [Related]
5. Modulation of Viability, Proliferation, and Stemness by Rosmarinic Acid in Medulloblastoma Cells: Involvement of HDACs and EGFR.
Laschuk Herlinger A; Lovatto Michaelsen G; Sinigaglia M; Fratini L; Nogueira Debom G; Braganhol E; Brunetto de Farias C; Lunardi Brunetto A; Tesainer Brunetto A; da Cunha Jaeger M; Roesler R
Neuromolecular Med; 2023 Dec; 25(4):573-585. PubMed ID: 37740824
[TBL] [Abstract] [Full Text] [Related]
6. CDK7 and CDK9 inhibition interferes with transcription, translation, and stemness, and induces cytotoxicity in GBM irrespective of temozolomide sensitivity.
Bhutada I; Khambati F; Cheng SY; Tiek DM; Duckett D; Lawrence H; Vogelbaum MA; Mo Q; Chellappan SP; Padmanabhan J
Neuro Oncol; 2024 Jan; 26(1):70-84. PubMed ID: 37551745
[TBL] [Abstract] [Full Text] [Related]
7. Stationary-to-migratory transition in glioblastoma stem-like cells driven by a fatty acid-binding protein 7-RXRα neurogenic pathway.
Liu RZ; Choi WS; Jain S; Xu X; Elsherbiny ME; Glubrecht DD; Tessier AG; Easaw JC; Fallone BG; Godbout R
Neuro Oncol; 2023 Dec; 25(12):2177-2190. PubMed ID: 37499046
[TBL] [Abstract] [Full Text] [Related]
8. Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations.
Martell E; Kuzmychova H; Senthil H; Kaul E; Chokshi CR; Venugopal C; Anderson CM; Singh SK; Sharif T
Acta Neuropathol Commun; 2023 Jul; 11(1):110. PubMed ID: 37420311
[TBL] [Abstract] [Full Text] [Related]
9. Chi3l1 Is a Modulator of Glioma Stem Cell States and a Therapeutic Target in Glioblastoma.
Guetta-Terrier C; Karambizi D; Akosman B; Zepecki JP; Chen JS; Kamle S; Fajardo JE; Fiser A; Singh R; Toms SA; Lee CG; Elias JA; Tapinos N
Cancer Res; 2023 Jun; 83(12):1984-1999. PubMed ID: 37101376
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA GSCAR promotes glioma stem cell maintenance via stabilizing sox2 expression.
Jiang X; Zhang Y; Yuan Y; Jin Z; Zhai H; Liu B; Li Y; Zhang C; Chen M; Shi Y; Yan D; Pu J; Chen Y; Yang C
Int J Biol Sci; 2023; 19(6):1681-1697. PubMed ID: 37063420
[TBL] [Abstract] [Full Text] [Related]
11. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.
Martínez-Bosch N; Vilariño N; Alameda F; Mojal S; Arumí-Uria M; Carrato C; Aldecoa I; Ribalta T; Vidal N; Bellosillo B; Menéndez S; Del Barco S; Gallego O; Pineda E; López-Martos R; Hernández A; Mesia C; Esteve-Codina A; de la Iglesia N; Balañá C; Martínez-García M; Navarro P
Cells; 2023 Mar; 12(6):. PubMed ID: 36980184
[TBL] [Abstract] [Full Text] [Related]
12. VAV3 regulates glioblastoma cell proliferation, migration, invasion and cancer stem‑like cell self‑renewal.
Miao R; Huang D; Zhao K; Li Y; Zhang X; Cheng Y; Guo N
Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36960857
[TBL] [Abstract] [Full Text] [Related]
13. Generation of mesenchymal stromal cells from urine-derived iPSCs of pediatric brain tumor patients.
Baliña-Sánchez C; Aguilera Y; Adán N; Sierra-Párraga JM; Olmedo-Moreno L; Panadero-Morón C; Cabello-Laureano R; Márquez-Vega C; Martín-Montalvo A; Capilla-González V
Front Immunol; 2023; 14():1022676. PubMed ID: 36776860
[TBL] [Abstract] [Full Text] [Related]
14. Identification and gene expression profiling of human gonadotrophic pituitary adenoma stem cells.
Yuan L; Li P; Li J; Peng J; Zhouwen J; Ma S; Jia G; Jia W; Kang P
Acta Neuropathol Commun; 2023 Feb; 11(1):24. PubMed ID: 36750863
[TBL] [Abstract] [Full Text] [Related]
15. WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma.
Mitchell K; Sprowls SA; Arora S; Shakya S; Silver DJ; Goins CM; Wallace L; Roversi G; Schafer RE; Kay K; Miller TE; Lauko A; Bassett J; Kashyap A; D'Amato Kass J; Mulkearns-Hubert EE; Johnson S; Alvarado J; Rich JN; Holland EC; Paddison PJ; Patel AP; Stauffer SR; Hubert CG; Lathia JD
Genes Dev; 2023 Feb; 37(3-4):86-102. PubMed ID: 36732025
[TBL] [Abstract] [Full Text] [Related]
16. Targeting the epigenome of cancer stem cells in pediatric nervous system tumors.
Freire NH; Jaeger MDC; de Farias CB; Nör C; Souza BK; Gregianin L; Brunetto AT; Roesler R
Mol Cell Biochem; 2023 Oct; 478(10):2241-2255. PubMed ID: 36637615
[TBL] [Abstract] [Full Text] [Related]
17. Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling.
Lee D; Gimple RC; Wu X; Prager BC; Qiu Z; Wu Q; Daggubati V; Mariappan A; Gopalakrishnan J; Sarkisian MR; Raleigh DR; Rich JN
J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36394953
[TBL] [Abstract] [Full Text] [Related]
18. Single-nucleus transcriptomics of IDH1- and TP53-mutant glioma stem cells displays diversified commitment on invasive cancer progenitors.
Gulaia V; Shmelev M; Romanishin A; Shved N; Farniev V; Goncharov N; Biktimirov A; Vargas IL; Khodosevich K; Kagansky A; Kumeiko V
Sci Rep; 2022 Nov; 12(1):18975. PubMed ID: 36348001
[TBL] [Abstract] [Full Text] [Related]
19. Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation.
Lakis NS; Brodsky AS; Karashchuk G; Audesse AJ; Yang D; Sturtevant A; Lombardo K; Wong IY; Webb AE; Anthony DC
Acta Neuropathol Commun; 2022 Nov; 10(1):159. PubMed ID: 36333778
[TBL] [Abstract] [Full Text] [Related]
20. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
[TBL] [Abstract] [Full Text] [Related]
[Next]
